Antag Therapeutics
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- $86M
Investors
- 7
About Antag Therapeutics
Founded in 2017 by Mette M. Rosenkilde and Jens J. Holst and based in Copenhagen, Denmark, Antag Therapeutics ApS is a preclinical-stage biotechnology company that specializes in the treatment of related metabolic diseases. Sparre-Ulrich. The company specializes in offering therapeutic peptides that are peptide-based GIP receptor antagonists’ development so that metabolic illnesses connected to diet can be monitored via infusion. This allows the healthcare sector to reduce body fat, lipid uptake, and blood flow. The primary use of these peptides is subcutaneous injection for self-administration, which focuses on treating obesity and postural orthostatic tachycardia syndrome (POTS).
Who invested in Antag Therapeutics
7 investors across 1 round
See all investors in Antag Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 29, 2024
Amount
$86M
Investors
Questions about Antag Therapeutics
Who invested in Antag Therapeutics?
Antag Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antag Therapeutics raised?
Antag Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Antag Therapeutics last raise money?
Antag Therapeutics's most recent round on record is a Series A, in Nov 2024.
What does Antag Therapeutics do?
Antag Therapeutics is a biotechnology company.
Where is Antag Therapeutics headquartered?
Antag Therapeutics is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Antag Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Antag Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Antag Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.